| 000 | 01896 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518071743.0 | ||
| 264 | 0 | _c20210601 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a1600-0625 | ||
| 024 | 7 |
_a10.1111/exd.14061 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKiss, Borbála | |
| 245 | 0 | 0 |
_aPoly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis. _h[electronic resource] |
| 260 |
_bExperimental dermatology _c01 2020 |
||
| 300 |
_a79-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImiquimod _xpharmacology |
| 650 | 0 | 4 |
_aInflammation _xgenetics |
| 650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
| 650 | 0 | 4 | _aKeratinocytes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aPoly (ADP-Ribose) Polymerase-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPsoriasis _xchemically induced |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTRPV Cation Channels _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTh17 Cells |
| 700 | 1 | _aSzántó, Magdolna | |
| 700 | 1 | _aHegedűs, Csaba | |
| 700 | 1 | _aAntal, Dóra | |
| 700 | 1 | _aSzödényi, Annamária | |
| 700 | 1 | _aMárton, Judit | |
| 700 | 1 | _aMéhes, Gábor | |
| 700 | 1 | _aVirág, László | |
| 700 | 1 | _aSzegedi, Andrea | |
| 700 | 1 | _aBai, Péter | |
| 773 | 0 |
_tExperimental dermatology _gvol. 29 _gno. 1 _gp. 79-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/exd.14061 _zAvailable from publisher's website |
| 999 |
_c30340634 _d30340634 |
||